plastic surgery, hollywood plastic surgery, plastic surgery, hollywood plastic surgery, plastic surgery, hollywood plastic surgery, plastic surgery, plastic surgery photo, hollywood plastic surgery, plastic surgery prices, plastic surgery, bad credit plastic surgery financing

plastic surgery | hollywood plastic surgery Information

plastic surgery Resources

hollywood plastic surgery News

Friday, December 02, 2005





SCOTTSDALE, Ariz. -- MedElite, Inc. Will Exhibit Its Talsyn(TM)-CI/bid Scar Cream in Booth 329 at McCormick Place Convention Center in Chicago, IL on September 24-28, 2005

Dr. Richard Goldfarb, M.D., FACS, President of MedElite, Inc., a wholly-owned subsidiary of eFoodSafety.com, Inc. (OTCBB:EFSF), announced today that MedElite, Inc. has been accepted to be an Exhibitor of its Talsyn(TM)-CI/bid Scar Cream at the most prestigious show for physicians in the field of Plastics and Reconstructive Surgery in Chicago, Illinois, September 24-28, 2005. Talsyn(TM)-CI/bid Scar Cream (www.talsyn.com) is a specially designed compound for the management of Keloids, Hypertrophic Scars, Erythema, and Surgical Incisions. Talsyn(TM) has been clinically proven to facilitate healing and improve the appearance, redness, and strength of scars.

"After a careful review by The American Society of Plastic Surgeons, we were granted the opportunity to show our revolutionary scar cream product to the thousands of attendees at the show. A majority of physicians who deal with scars in their everyday practice will have full exposure to our technology and be able to sample this product, creating the comfort level needed to dispense our Talsyn(TM)-CI/bid Scar Cream to their patients," stated Dr. Goldfarb.

The American Society of Plastic Surgeons (ASPS) is the largest specialty organization in the world. Founded in l93l, the Society is composed of board-certified plastic surgeons who perform cosmetic and reconstructive surgery. The mission of ASPS is to advance quality care to patients by encouraging high standards of training, ethics, physician practice and research in (www.plasticsurgery.org).

"This acceptance to exhibit by The American Society of Plastic Surgeons in the $4 billion scar cream market will allow MedElite, Inc. to reach mass numbers of physicians dealing with the MOST important aspect of Plastic Surgery - 'the scar'" added Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, and avian influenza. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration; in the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's recently announced acquisition of MedElite, Inc. is expected to provide recurring revenue to the company. MedElite, Inc. distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and Worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com).

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.



COPYRIGHT 2005 Business Wire